Variations among Institutional Review Board reviews in a multisite health services research study
- PMID: 15663713
- PMCID: PMC1361137
- DOI: 10.1111/j.1475-6773.2005.00353.x
Variations among Institutional Review Board reviews in a multisite health services research study
Abstract
Objective: To document the Institutional Review Board (IRB) review process and to explore the impact of different patient notification procedures.
Data sources/study setting: Review of IRB application and correspondence records prospectively collected during a multisite study of health care quality involving telephone interviews of 3,000 participants across 15 primary care sites.
Study design: Records were reviewed to ascertain: (1) the type of IRB review conducted, (2) the number of days from submission to approval of the IRB application, (3) whether the IRB required patient notification and/or consent prior to the release of names, and (4) patient participation rates.
Data collection/extraction methods: The study coordinating center prepared a common study protocol for IRB submission and assisted sites with submission. The application, correspondence with the IRB, consent script, and patient letters were collected, reviewed, coded, and analyzed.
Principal findings: IRBs at the 15 sites and survey center varied in the type of IRB required and the number of days from submission to approval (range of 5-172 days). Four sites required patient notification in advance of the study; 2-11 percent of patients refused in opt-out sites and 37 percent in the single opt-in site. Participation among contacted patients did not appear to be related to patient notification procedures.
Conclusions: Variations in IRB requirements can affect response rates and sample generalizability.
Similar articles
-
Do patient consent procedures affect participation rates in health services research?Med Care. 2002 Apr;40(4):283-8. doi: 10.1097/00005650-200204000-00004. Med Care. 2002. PMID: 12021684
-
Impact of institutional review board practice variation on observational health services research.Health Serv Res. 2006 Feb;41(1):214-30. doi: 10.1111/j.1475-6773.2005.00458.x. Health Serv Res. 2006. PMID: 16430608 Free PMC article.
-
Time to institutional review board approval with local versus central review in a multicenter pragmatic trial.Clin Trials. 2018 Feb;15(1):107-111. doi: 10.1177/1740774517735536. Epub 2017 Oct 6. Clin Trials. 2018. PMID: 28982261 Clinical Trial.
-
Working with the institutional review board.Am J Health Syst Pharm. 2009 Jan 15;66(2):176-84. doi: 10.2146/ajhp070066. Am J Health Syst Pharm. 2009. PMID: 19139484 Review.
-
Understanding institutional review boards: practical guidance to the IRB review process.Nutr Clin Pract. 2007 Dec;22(6):618-28. doi: 10.1177/0115426507022006618. Nutr Clin Pract. 2007. PMID: 18042949 Review.
Cited by
-
Research ethics committees in the UK--the pressure is now on research and development departments.J R Soc Med. 2005 Oct;98(10):444-7. doi: 10.1177/014107680509801007. J R Soc Med. 2005. PMID: 16199810 Free PMC article. Review. No abstract available.
-
Ethical oversight in quality improvement and quality improvement research: new approaches to promote a learning health care system.BMC Med Ethics. 2015 Sep 17;16(1):63. doi: 10.1186/s12910-015-0056-2. BMC Med Ethics. 2015. PMID: 26383770 Free PMC article. Review.
-
Prioritizing Initiatives for Institutional Review Board (IRB) Quality Improvement.AJOB Empir Bioeth. 2016;7(4):265-274. doi: 10.1080/23294515.2016.1186757. Epub 2016 Jun 23. AJOB Empir Bioeth. 2016. PMID: 32775502 Free PMC article.
-
Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform.Milbank Q. 2011 Dec;89(4):599-627. doi: 10.1111/j.1468-0009.2011.00644.x. Milbank Q. 2011. PMID: 22188349 Free PMC article. Review.
-
IRB Process Improvements: A Machine Learning Analysis.J Clin Transl Sci. 2017 Jun;1(3):176-183. doi: 10.1017/cts.2016.25. Epub 2017 Apr 26. J Clin Transl Sci. 2017. PMID: 29082031 Free PMC article.
References
-
- Anderson RT, Weisman CS, Scholle SH, Henderson JT, Oldendick R, Camacho F. “Evaluation of the Quality of Care in the Clinical Centers of the National Centers of Excellence in Women's Health.”. Women's Health Issues. 2002;12(6):309–326. - PubMed
-
- Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. “Survival of Blacks and Whites after a Cancer Diagnosis.”. Journal of the American Medical Association. 2002;287:2106–2113. - PubMed
-
- Bennett CL, Sipler AM, Parada JP, Goetz MB, De Horitz JA, Weinstein RA. “Variations in Institutional Review Boards Decisions for HIV Quality of Care Studies: A Potential Source of Study Bias.”. Journal of Acquired Immune Deficiency Syndrome. 2001;26:390–391. - PubMed
-
- Brook RH, McGlynn EA, Cleary PD. “Quality of Health Care. Part 2: Measuring Quality of Care.”. New England Journal of Medicine. 1996;335:966–970. - PubMed
-
- Burman WJ, Reves R, Cohn D, Schooley R. “Breaking the Camel's Back: Multicenter Clinical Trials and Local Institutional Review Boards.”. Annals of Internal Medicine. 2001;134:152–157. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources